Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
Date:10/30/2008

r />

Mylan Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(unaudited; in thousands, except per share amounts)

Three Months Ended Nine Months Ended

September 30, September 30, September 30, September 30,

2008 2007 2008 2007

Net revenues $1,191,010 $472,400 $3,440,680 $1,498,809

Other revenues 465,838 4,691 493,750 11,865

Total revenues 1,656,848 477,091 3,934,430 1,510,674

Cost of sales 745,711 255,450 2,258,863 757,478

Gross profit 911,137 221,641 1,675,567 753,196

Operating expenses:

Research and development 74,721 33,577 239,320 102,145

Acquired in-process

research and

development - - - 147,000

Impairment loss on

goodwill - - 385,000 -

Selling, general and

administrative 275,584 97,016 787,953 236,684

Litigation settlements,

net - (848) - (4,810)

Total operating expenses 350,305 129,745 1,412,273 481,019

Earnings from operations 560,832 91,896 263,294 272,177

Interest expense 87,553 23,107 264,789 67,010

Other income, net 5,766 166,832 20,583 140,923

Earnings before income

taxes and minority

interest 479,045 235,621 19,088 346,090

Income tax provision 272,438 88,498 197,378 190,455

Earnings (loss) before

minority interest 206,607 147,123 (178,290) 155,635

M
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
2. Mylan to Host Investor Day on October 3, 2007
3. Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
4. Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
5. Mylan Announces Tentative FDA Approval for Lamotrigine Tablets
6. Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
7. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
8. Mylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
9. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
10. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... MILAN , October 27, 2014 ... the right to produce, exhibit and sell its ... sought to impeach their patent.      ... After four years of fighting, the definitive judgement ... designs and produces innovative and accessible hi-tech prostheses ...
(Date:10/27/2014)... October 27, 2014 The “Molecular ... Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End ... Service, Software) - Global Forecast to 2018” provides ... challenges, opportunities, current market trends, and strategies impacting ... estimates and forecasts of the revenue and share ...
(Date:10/27/2014)... The report “Smart Highway Market ... Communication, Monitoring), and by Display (Variable Message Signs, ... the global market into various sub-segments with in-depth ... the drivers and restraints for this market with ... 75 market tables and 37 figures spread through ...
(Date:10/27/2014)... 2014 Investor-Edge has initiated coverage ... NBIX ), Insmed Inc. (NASDAQ: INSM ... Dyax Corporation (NASDAQ: DYAX ), and Oncothyreon ... can be accessed at: http://investor-edge.com/register . ... at 4,483.72, up 0.69%, the Dow Jones Industrial Average ...
Breaking Biology Technology:Italian Lower Limb Prosthesis Company Wins Lawsuit Against German Giant Ottobock 2Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 2Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 3Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 4Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 5Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 2Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 3Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 5
... 17 Alfacell Corporation,(Nasdaq: ACEL ) announced ... the,engagement of Oppenheimer & Co. as a financial ... strategic alternatives to enhance,shareholder value, including a possible ... but not be limited to, strategic partnership,transactions., ...
... (MBI) has been awarded a $625,000 contract under ... development of a Universal Sample,Preparation Module (USPM). The ... SBIR firms that have Phase II projects that ... products., MBI,s project will develop a Universal ...
... September 17 Sangui BioTech,International, Inc., is currently preparing ... 30, 2008). The ensuing report on form,10KSB will be ... course. It will be,included in the proxy materials for ... a letter by the SEC. Subsequently, the,shareholders, meeting will ...
Cached Biology Technology:Alfacell Hires Advisors to Advance Strategic Alternatives 2Alfacell Hires Advisors to Advance Strategic Alternatives 3Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program 2Sangui Bio Tech International Inc. Shareholders' Meeting Delayed to Include FY 2008 Report 2
(Date:10/28/2014)... German . ... sufficient food when times are lean? By studying wild ... researchers of the Max Planck Institute for Evolutionary Anthropology ... great apes can acquire extra energy needed to maintain ... sleeping nests more en route to breakfast sites containing ...
(Date:10/28/2014)... Singapore (NTU Singapore) will be building a hybrid ... sources. , The first in the region, the ... of solar, wind, tidal-current, diesel, storage and power-to-gas ... together. , To be built under the new ... hybrid micro-grid will be located offshore at Semakau ...
(Date:10/27/2014)... Ga. – Multiple times each day, about a third ... pressure – for at least an hour after the ... , Now they want to know how chronic mental ... response so they can determine the best ways to ... sodium is bad for you – these patients have ...
Breaking Biology News(10 mins):The early chimp gets the fig 2The early chimp gets the fig 3NTU to build region's first renewable energy integration demonstration micro-grid 2NTU to build region's first renewable energy integration demonstration micro-grid 3Researchers look for the best way to help shake too much sodium 2Researchers look for the best way to help shake too much sodium 3Researchers look for the best way to help shake too much sodium 4
... and the debriefing today, the Russian State Commission has given ... CEST. Today,s go-ahead marks the last milestone along the ... tiny variations in the thickness of ice floating in the ... land, the mission will provide scientists with hard evidence on ...
... of Pittsburgh provides the first identification of a human ... in products from electronics to plasticsand in laboratory tests ... to the tiny components, according to findings published online ... open the door to the use of carbon nanotubes ...
... After years of preparation and anticipation, scientists who discover ... key question about Alzheimer,s disease: Will drugs that block ... called amyloid-beta slow the progression of the devastating disease? ... Chemical & Engineering News (C&EN), ACS, weekly newsmagazine, ...
Cached Biology News:CryoSat-2 ready for launch 2Pitt-led study identifies human enzyme that breaks down potentially toxic nanomaterials 2Pitt-led study identifies human enzyme that breaks down potentially toxic nanomaterials 3
Rabbit polyclonal to Synapsin II ( Abpromise for all tested applications). entrezGeneID: 6854 SwissProtID: Q92777...
... are designed for sequencing inserts cloned into ... or T3 RNA polymerase promoters, or lambda ... at a concentration of 0.1 µg/µl in ... DNA sequencing reactions using SequiTherm™ EXCEL™ II ...
BD BioCoat Fibronectin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of human fibronectin....
... CLS number is a new product ... product number. If showing no availability ... Sigma-Aldrich number (C6671) or contact customer ... yes Surface area 148 cm 2 ...
Biology Products: